|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| C12Q 1/6886 | (2013.01) |
| (11) | Patento numeris | 3436601 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17715124.8 |
| Europos patento paraiškos padavimo data | 2017-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/057752 |
| Data | 2017-03-31 |
| (87) | Numeris | WO 2017/167989 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 16305380 | 2016-03-31 | EP |
| (72) |
AMOR-GUERET, Mounira , FR
MAMERI, Hamza , FR
|
| (73) |
Centre National de la Recherche Scientifique ,
3, rue Michel-Ange, 75016 Paris,
FR
Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR |
| (54) | CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET |
| CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET |